meglumine antimoniate has been researched along with Nasal Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Confort, EM; da Costa, DC; da Silva, AF; Madeira, Mde F; Martins, AC; Moreira, JS; Palmeiro, MR; Quintella, LP; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM | 1 |
| Aguirre-Urizar, JM; Araluce-Iturbe, I; Crovetto-De la Torre, MA; Crovetto-MartÃnez, R; Orte-Aldea, C; Whyte-Orozco, J | 1 |
| El kartouti, A; Elbenaye, J; Miloudi, M | 1 |
| Abbas, O; Alam, E; Khalifeh, I; Moukarbel, R | 1 |
| Figueroa, RA; Miranda, MC; Prager, M; Zea, DF | 1 |
| Achour, I; Chakroun, A; Charfeddine, I; Ghorbel, A; Hammami, B; Mnejja, M; Turki, H | 1 |
| Bouassida, S; Kitar, A; Masmoudi, A; Rebai, M; Turki, H; Zahaf, A | 1 |
7 other study(ies) available for meglumine antimoniate and Nasal Diseases
| Article | Year |
|---|---|
Oral manifestations in the American tegumentary leishmaniasis.
Topics: Antiprotozoal Agents; Female; Humans; Larynx; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nose; Nose Diseases; Organometallic Compounds; Pharynx; Prognosis; Retrospective Studies | 2014 |
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Combined Modality Therapy; Diagnosis, Differential; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Nose Diseases; Organometallic Compounds | 2015 |
[Erysipeloid cutaneous leishmaniasis: about a clinical observation].
Topics: Adult; Antiprotozoal Agents; Erysipeloid; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds | 2015 |
Cutaneous Leishmaniasis: An Overlooked Etiology of Midfacial Destructive Lesions.
Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Young Adult | 2016 |
[Mucosal complication of cutaneous leishmaniasis].
Topics: Aged; Anemia; Antiprotozoal Agents; Contraindications; Eyelid Diseases; Humans; Hypertension; Kidney Failure, Chronic; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds; Phosphorylcholine | 2009 |
Unusual form of cutaneous leishmaniasis: erysipeloid form.
Topics: Antiprotozoal Agents; Biopsy; Diagnosis, Differential; Erysipeloid; Facial Dermatoses; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Skin | 2011 |
[The cutaneous leishmaniasis of the face in Gafsa area, Tunisia].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Endemic Diseases; Facial Dermatoses; Female; Humans; Incidence; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Necrosis; Nose Diseases; Organometallic Compounds; Prospective Studies; Skin Ulcer; Tunisia | 2005 |